Search

everythinglearnresearchcommunity

for

Search:↓

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Baricitinib shows promise in treating severe hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Cedrol may be an effective treatment for colorectal cancer.

Tofacitinib treatment is used for teenagers with alopecia areata.

Imuvert can prevent some chemotherapy-induced hair loss.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Gefitinib therapy can cause unusual hair growth on the nose.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.